YAKHAK HOEJI (약학회지)

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Evaluation of Adults' Knowledge on Generic Medications in Korea

지역약국 방문 성인의 제네릭 의약품 인식도 평가

  • Lee, Yu-Jeung (Graduate School of Clinical Pharmacy, Sookmyung Women's University)
  • 이유정 (숙명여자대학교 임상약학대학원)
  • Received : 2010.12.23
  • Accepted : 2011.04.28
  • Published : 2011.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Generic medication market has been increased for economic reasons in Korea. Health authorities worldwide recommend the use of generic medications nowadays. However, patients in Korea are not familiar with the generic medications and considerable percent of those do not know the definition of the generic medications. The purpose of this study was to evaluate adults' knowledge and perception on the generic medications at community pharmacies in Korea. This study was a 11-questionnaire survey conducted from August 9, 2010 to August 27, 2010. Of the 204 respondents, 63 (30.9%) responded that they knew what a generic medication was, but only 16 (25.4%) of those answered that generic medications had the same efficacy as brand medications. When pharmacists were the source of generic medication information, more patients reported having knowledge about the definition of generic medications correctly compared with other sources. Patients with negative experience with generic medications within 6 months were more reluctant to generic substitution suggested by a pharmacist than those with positive experience. Based on the results of this study, further studies should be conducted to establish the best way to provide generic medication information for patients.

Keywords

References

  1. 제네릭의약품 정보방. Copyright${\copyright}$ 2009 Korea Food & Drug Administration. http://opendrug.kfda.go.kr/generic/genericInfo/summary/generic01.jsp (accessed on December 20, 2010).
  2. Meyer, M. C. : United States Food and Drug Administration requirements for approval of generic drug products. J. Clin. Psychol. 62, 4 (2001).
  3. Perry, G. : The European pharmaceutical market in review: 2006 and beyond. J. Generic Med. 4, 4 (2006). https://doi.org/10.1057/palgrave.jgm.4950041
  4. Industry Report(제약산업). 한국신용평가정보. 2007.8. (2007).
  5. Kanavos, P. and Taylor, D. : Pharmacy discounts on generic medicines in France: is there room for further efficiency savings? Curr. Med. Res. Opin. 23, 2467 (2007). https://doi.org/10.1185/030079907X219571
  6. Meredith, P. A. : Generic drugs. Therapeutic equivalence. Drug Saf. 15, 233 (1996). https://doi.org/10.2165/00002018-199615040-00001
  7. Meredith, P. : Bioequivalence and other unresolved issues in generic drug substitution. Clin. Ther. 25, 2875 (2003). https://doi.org/10.1016/S0149-2918(03)80340-5
  8. Mott, D. A. and Cline, R. R. : Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution. Med. Care 40, 662 (2002). https://doi.org/10.1097/00005650-200208000-00006
  9. Johnston, A. : Challenges of therapeutic substitution of drugs for economic reasons: focus on CVD prevention. Curr. Med. Res. Opin. 26, 871 (2010). https://doi.org/10.1185/03007990903578462
  10. Hellstrom, J. and Rudholm, N. : Side effects of generic competition? Eur. J. Health Econ. 5, 203 (2004). https://doi.org/10.1007/s10198-004-0234-5